X0306 4 2019-11-21 0 0001492658 Wright Medical Group N.V. WMGI 0001678421 Lanier Tim 1023 CHERRY ROAD MEMPHIS TN 38117 0 1 0 0 President, Upper Extremities Ordinary Shares, par value EUR 0.03 per share 2019-11-21 4 M 0 36723 21.24 A 61682 D Ordinary Shares, par value EUR 0.03 per share 2019-11-21 4 M 0 6523 27.86 A 68205 D Ordinary Shares, par value EUR 0.03 per share 2019-11-21 4 M 0 3671 24.49 A 71876 D Ordinary Shares, par value EUR 0.03 per share 2019-11-21 4 S 0 46917 29.4946 D 24959 D Stock Option (right to buy) 21.24 2019-11-21 4 M 0 36723 0 D 2026-07-19 Ordinary Shares 36723 7395 D Stock Option (right to buy) 27.86 2019-11-21 4 M 0 6523 0 D 2027-07-25 Ordinary Shares 6523 5084 D Stock Option (right to buy) 24.49 2019-11-21 4 M 0 3671 0 D 2028-07-24 Ordinary Shares 3671 8080 D Exercise and sale of vested stock options in connection with 280G tax planning. Includes 3,946 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2010 Incentive Plan, 5,251 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan and 4,739 shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2017 Equity and Incentive Plan. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.48 to $29.52, inclusive. The reporting person undertakes to provide to Wright Medical Group N.V., any security holder of Wright Medical Group N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4. This option vested with respect to 25% of the shares on July 19, 2017 and with respect to the remaining 75% of such shares over the three-year period thereafter in 36 as nearly equal as possible monthly installments. This option vested with respect to 25% of the shares on July 25, 2018 and with respect to the remaining 75% of such shares over the three-year period thereafter in 36 as nearly equal as possible monthly installments. This option vested with respect to 25% of the shares on July 24, 2019 and with respect to the remaining 75% of such shares over the three-year period thereafter in 36 as nearly equal as possible monthly installments. /s/ Marija Nelson, attorney-in-fact 2019-11-22